On Demand Webinars and E-Journal Clubs

Comparison of the Analytical Sensitivity of Blood Donor Screening versus Diagnostic Molecular Tests for the Detection of Zika Virus RNA: A PASCV E-Journal Club Discussion

 

Webinar Access

Click here to access the webinar. Recording is available to members only. 


P.A.C.E.® (1.0 Contact Hour)
Click here to receive P.A.C.E. ® credit. 
PASCV members MUST be logged into their account when completing the Program Evaluation to earn credit.

 

Zika virus continues to circulate and remains a significant concern in the Americas.  Over the past year, multiple different nucleic acid amplification tests (NAATs) have been developed to detect Zika virus RNA, and these assays can be categorized as either blood donor screening tests for use in blood donation centers or as diagnostic assays for use in clinical virology laboratories.

 

A recent, international, multicenter study evaluated the analytical sensitivity of Zika virus NAATs for blood donor screening compared to those designed for diagnostic purposes. For this E-Journal Club, our three-member panel will discuss the results of this study, entitled “Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA” in the journal Transfusion 2017;57(3):734-747.

 


What is Droplet Digital PCR (ddPCR) and Will It Be Found in Clinical Virology Laboratories of the Future?

 

Webinar Access

Click here to access the webinar. Recording is available to members only. 

 

P.A.C.E.® (1.0 Contact Hour)
Click here to receive P.A.C.E. ® credit. 
PASCV members MUST be logged into their account when completing the Program Evaluation to earn credit.

 

The webinar will discuss what digital PCR is, describe the 2 major types (droplet digital PCR and chip or chamber digital PCR), and identify the currently available instrumentation.  The advantages and disadvantages of the current droplet digital PCR methods and technology will be presented.  Current assays being used both clinically and in research studies will be presented to highlight a variety of applications being developed with this technology.



HIV Diagnostics: Updates in Laboratory Testing and Algorithms Interpretation

This webinar is jointly sponsored by PASCV, AMP, and APHL.

 

Webinar Access

Click here to access the webinar. Recording is available to members only. 

 

P.A.C.E.® (1.0 Contact Hour)
Click here to receive P.A.C.E. ® credit. 
PASCV members MUST be logged into their account when completing the Program Evaluation to earn credit.

 

Laboratory diagnostics of HIV continue to evolve with antigen/antibody and molecular methods becoming increasingly more sensitive, specific, and rapid. Moreover, laboratory implementation of the CDC/APHL testing algorithm incorporating these assays may result in improved diagnosis of acute HIV but may also be challenging to interpret. The overall goal of this webinar is to discuss diagnostic methods for HIV and the current testing algorithm through the presentation of actual clinical cases. The webinar will conclude with a brief discussion of emerging or novel diagnostic methods and their impact on HIV diagnosis. 

 

  

The Utility of Broad Detection of Respiratory Pathogens: A PASCV E-Journal Club Discussion

Webinar Access

Click here to access the webinar. Recording is available to members only. 

 

P.A.C.E.® (1.0 Contact Hour)
Click here to receive P.A.C.E. ® credit. 
PASCV members MUST be logged into their account when completing the Program Evaluation to earn credit.

 

In this first-ever on-line journal club, three discussants will highlight important background, investigational methods, results and interpretation of an outcomes study described in “Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia “ authored by Gadsby NJ et al, in Clinical Infectious Diseases 2016;62 (7):817–23.The online audience can follow the discussion using audiovisuals that will include an annotated pdf of the paper.

 


Zika Virus: Diagnostic Testing and Front-Line Management 

This webinar is jointly sponsored by PASCV and AMP.


Webinar Access 

Click here to access the webinar. 


Zika virus (ZIKV) is an Aedes mosquito-borne flavivirus that emerged in Brazil in 2015 and then rapidly spread throughout the tropical and subtropical Americas. Based on clinical criteria alone, ZIKV cannot be reliably distinguished from infections with other pathogens that cause an undifferentiated systemic febrile illness, including infections with two common arboviruses, dengue virus and chikungunya virus. This presentation details the methods that are available to diagnose ZIKV infection. This presentation will review epidemiology of Zika outbreak in Latin America, some clinical aspects, evidence of zika infection and its complications (congenital disease and Guillain Barre Syndrome), local information of our series of travelers infected with Zika including a pregnant women and sexual transmitted infection.


 

NAATs for Rapid Detection of Influenza Virus: Time for a Paradigm Shift?

 

Webinar Access 

Click here to access the webinar. Recording is available to members only.

 

Influenza is a contagious respiratory illness that can be quite serious and result in significant hospitalization and death, particularly in the very young, the elderly, and individuals with underlying comorbid conditions.  Rapid and accurate detection of influenza disease can play an important role in clinical care and management, but detection of influenza viruses using traditional methods can be challenging.  In this program, we will explore the latest advances in molecular technology for the rapid detection of influenza viruses, discuss some of the issues surrounding these methods, and describe the potential impact of these newer tests on patient care and health-related outcomes.

 

Association Management Software Powered by YourMembership  ::  Legal